Literature DB >> 10458721

Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries.

K Hata1, P Whittaker, R A Kloner, K Przyklenk.   

Abstract

BACKGROUND: Brief antecedent periods of coronary artery occlusion improve subsequent vessel patency in damaged and stenotic coronary arteries via release of adenosine from ischemic/reperfused myocardium and resultant adenosine receptor stimulation. However, the site of receptor stimulation-circulating blood-borne elements (ie, platelets) versus vessel-wall components of the culprit artery-remains unclear. If platelet adenosine receptors are involved, then the benefits of brief coronary occlusion (1) should be manifested systemically and improve patency at a remote site and (2) should be inhibited by an antagonist of adenosine A(2) receptors, whereas, in contrast, (3) brief vascular occlusion not associated with appreciable adenosine release should be ineffective in improving vessel patency. METHODS AND
RESULTS: In Protocol 1, anesthetized rabbits received 5 minutes of transient coronary occlusion, 5 minutes of transient bilateral carotid occlusion (purported to cause negligible adenosine release from the brain), or no intervention. All rabbits then underwent injury plus stenosis of the left carotid artery, resulting in repeated cyclic variations in carotid blood flow (CFVs). Carotid patency during the initial 2 hours after stenosis (assessed by quantifying the nadir of the CFVs and area of the flow-time profile) was significantly enhanced with antecedent coronary-but not carotid-occlusion versus controls. In Protocol 2, improvement in carotid patency after brief coronary occlusion was corroborated in anesthetized dogs. However, the benefits of brief coronary occlusion were abrogated by the A(2)/A(1) antagonist CGS 15943.
CONCLUSIONS: Brief antecedent coronary artery occlusion enhanced vessel patency in remote, damaged, and stenotic carotid arteries, largely due to adenosine receptor stimulation on circulating elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458721     DOI: 10.1161/01.cir.100.8.843

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Adenosine and blood platelets.

Authors:  Hillary A Johnston-Cox; Katya Ravid
Journal:  Purinergic Signal       Date:  2011-02-08       Impact factor: 3.765

2.  New insights into the regulation of inflammation by adenosine.

Authors:  Joel Linden
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

4.  Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  Lasers Med Sci       Date:  2007-03       Impact factor: 3.161

5.  Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction.

Authors:  D Rimar; E Crystal; A Battler; S Gottlieb; D Freimark; H Hod; V Boyko; L Mandelzweig; S Behar; J Leor
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

6.  Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

Authors:  Matthew D Linden; Marc R Barnard; A L Frelinger; Alan D Michelson; Karin Przyklenk
Journal:  Thromb Res       Date:  2007-08-28       Impact factor: 3.944

Review 7.  AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.

Authors:  Ryszard T Smolenski; Iwona Rybakowska; Jacek Turyn; Paweł Romaszko; Magdalena Zabielska; Anne Taegtmeyer; Ewa M Słomińska; Krystian K Kaletha; Paul J R Barton
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.